FDA Mandates New Warnings for Opioid and Benzodiazepines
Posted on September 20, 2016 by Rita Wilson
In a statement released on September 1, 2016 (FDA Black Box Warning), the Food and Drug Administration (FDA) announced that “after an extensive review of the latest scientific evidence, it is requiring class-wide changes to drug labeling, including patient information,…
For Media Inquires, Contact:
Helen King Patterson
813.690.4787
helen@kingknight.com
Search our blog:
Contact Us for a FREE Consultation